Member Info for Bella6532

Gkb.. 'I'm not sure that information from Morningstar is up to date, the percentages do not stack up with the current number of shares (do the calcs) which makes me suspect they are somewhat out of date.'
The share holding is correct but the % is not because they haven't taken the new admitted placing share adjustments into account. I assume because there was no buyi g or selling of shares.

If this is up to date, Landsdown is no longer shown as still holding.
On 11 May the last TR-1 reported a holding of 11.69m.
https://www.morningstar.com/stocks/xlon/sng/ownership
If you move the bar you can see the recent buy & Sell history for each Fund/II.
Polar Capital Biotech was new in with 5.7m on 30 April and Polar Capital LLP New in on 31 May with 5.7m but again if this is the case (assuming they are not duplicates) then how come they didn't report their buy in to SNG so TR-1's could be issued both on the Landsdown sell off and Polar Capital purchase(s) - the first threshold is 3% and that's only 4.48m!!!!!
Miton Truts also new in with 3.0m
Overall the total volumes are to the positive.
So if accurate the Landsdown shares were easily lapped up and reporting has been held off by all parties until all deals have been done (including the Link deal) to keep the price firmly down.
Now it will be interesting to see what, if anything!!!!, we get next week....

'Clinical trials will end when the vaccine has clearly been found to protect people...' Once you vaccinate people in a trial you then have to wait to see if they catch Covid19 to make sure the vaccine works. It is still not clear how long anti-bodies will last either. People still catch flu and die in very large numbers each year from it even though a vaccination is made available annually. Covid is not going to be any different. It's here to stay and there will be a need for a vaccine and Treatment like SNG001 to be available along side each other.

Oops sorry.. This should work.. https://amp-ft-com.cdn.ampproject.org/v/s/amp.ft.com/content/df295d01-c057-4827-b75c-7a3f2154757f?amp_js_v=a3&_gsa=1&usqp=mq331AQFKAGwASA%3D#referrer=https%3A%2F%2Fwww.google.com&_tf=From%20%251%24s&share=https%3A%2F%2Fwww.ft.com%2Fcontent%2Fdf295d01-c057-4827-b75c-7a3f2154757f

https://amp-ft-com.cdn.ampproject.org/v/s/amp.ft.com/content/df295d01-c057-4827-b75c-7a3f2154757f?

https://amp-ft-com.cdn.ampproject.org/v/s/amp.ft.com/content/df295d01-c057-4827-b75c-7a3f2154757f?

Haha... Deal and price agreed... Price based on asset value...who would benefit from an SP at today's price verses a few weeks ago and once transacted they will be sitting pretty ready for results...
If SNG is part of the asset sale then it's pretty obvious now what's been going on...
If they're not then I take this all back...

They're not giving individual assets involved until they are all tranacted. So still don't know.
Can we assume Synairgen was listed under their healthcare classification...?

I do wonder about the TR-1 reporting methods.
It's up to the shareholder to pass the threshold crossing details onto the company and then the company reports it to the markets. The company has no way of knowing what's going on until they receive the information from the shareholder. The date a threshold is crossed isn't usually the date all the shares were trades. I know the 1% threshholds are to try and help the markets but one does wonder at times!!!!...
SNG unfortunately has given us all July as the next major timeframe and I'm sure many out there will be using this to their advantage.
Sigh...

What target are they referring to?
Full recruitment in hospital trial (we know about) or ditto for home trial (we don't know about yet)?

SP Angel this morning:
'Bushveld Minerals* (BMN LN) 13.75p, Mkt cap £158m – Vanadium prices take off on news of strong demand from China
• Bushveld Minerals shares look set to recover on rising ferro-vanadium prices.
• Strong demand for steel and particularly structural steel in China is expected to drive demand for ferro-vanadium which is used to strengthen steel.
• Better enforcement of the higher-vanadium content regulations introduced in October 2018 should also increase demand particularly for new state-sponsored infrastructure projects.
• We expect Beijing to shortly announce a raft of new construction initiatives and projects to restore economic growth
• FastmarketsMB trade log shows ferro-vanadium prices indicated at $29-30.50/kg in China
• Ferro-vanadium 78% fob China rose $3.5% to $29 - 30.5 /kgV this week (FastmarketsMB)
• Vanadium pentoxide 98% rose 8.4% to $6.5 – 7/lb V2O5 this week (FastmarketsMB)
• Ferro Vanadium 80% FOB (China) rose to US$29.5/kgV vs US$29.0/kgV (Asia Metals)
• Vanadium prices suffered relatively little negative impact through the coronavirus due to the interruption of production of secondary by-product vanadium from the smelting of other concentrates.
• Increased use of higher-grade Australian iron ore which carries less vanadium content means that steel producers need to add more ferro-vanadium into their feedstock.
• This is expected to drive steel producers to buy more ferro-vanadium in the open market.
• Demand for vanadium electrolyte for VRFB systems is also expected to rise.
• Bushveld is a significant stakeholder in Invinity Energy Systems PLC which was created through the merger of RedT and Avalon. Invinity shares have more than doubled since the companies were combined.
• Bushveld now holds 8.71% in Invinit indicating the value of its stake has risen to £5.8m.
Conclusion: Bushveld Minerals has restarted its mine and processing plant following the 21 day lockdown in South Africa. While this will impact earnings in the first half we expect the company to make a strong recovery from here.

High dose intravenous can have some side effects especially around the injection site.. Not the same application as SNG001 which is via nebulizer and as far as I know has not been reported as high dose just that its a formulation...

Intravenous has has injection site issues in the past. That is why SNG is going for Nebulizer which administers direct to site of initial infected lung cells.

Can one assume if it works at point a patient is hospitalised it WILL be far more effective if administered earlier ie at home.

Any form of preventative medication should always be administered at the earliest possible stage and as direct to site of infection as possible. SNG001 as a easy to use Nebulizer ticks all the boxes... An injection does not.

Nolupus...that's pretty scary stuff in the link you posted.
'Is it possible that some of the extensive organ, tissue, and cellular damage done by SARS-CoV-2 is due to viral antigenic mimicry with human tissue?

If the answer is yes, then we may face an increase in the rates of autoimmune disease in the future, because any factor that causes chronic inflammation in the body can potentially induce autoimmune disease.'

All the more need for something to knock this virus on the head at the earliest possible moment.
Research/trial data from SNG's work with SNG001 for MS (an autoimmune disease) and COPD together with the current trials with Covid19 patients in hospital and at home should give them a very broad insight into SNG001's cell protection abilities and disease progression prevention.

'Tom Wilkinson, a professor of respiratory medicine at the University of Southampton, said, “We are hoping that the drug will increase the rate of recovery from infection, that it will increase the protection in the bit of the lungs that are not infected yet and will reduce the number of patients that decline significantly and require intubation and ventilation.”
https://www.pharmaceutical-technology.com/comment/synairgen-sng001-covid-19-trials/

'Reply from Fruitflow® Plus
Mar 14, 2020
Thank you very much for your feedback....'

Ah but he did reply to a comment in length on 14 March. Several paras worth in fact... Including shipping, subscriptions, product and research findings...
Alf.. What terms are you referring to in the AA? Confidentiality...?
There is plenty IF can refer to regarding FF which is already in the public domain... What he can't discuss is anything involving DSMs customers.

HappyDays2U...unfortunately the Govt is more likely to recommend taking a daily dose of Aspirin and Vit D.

Trustpilot is full of shareholders making recommendations. Joe Blow public is not that well informed. Even some of the nicknames give the game away.
I hope something is brewing. If buying shares for his sons should have been a big clue to long term holders on here.

https://www.nutraingredients-asia.com/Article/2019/04/02/China-health-claims-concerns-Huge-industry-uncertainty-as-regulator-embarks-on-regulations-review

'Adverse events were reported in 102 (66%) of 155 remdesivir recipients versus 50 (64%) of 78 placebo recipients. Remdesivir was stopped early because of adverse events in 18 (12%) patients versus four (5%) patients who stopped placebo early.'

Surely it's not just about recovery times it's about reducing or better still preventing adverse events. You could recover from Covid but still end up with a blood clot for example.

Sphinx 100... They'd better start showing a profit this time because you can add fundraising to that number too or will IF simply get a pay rise for having more hats or start funding a pension...